A new showcase series is reshaping NHS-supplier engagement. Pioneers at the first NHS host brought together hundreds of staff organisation-wide, along with major tech companies and niche innovators in a single day, already inspiring 10 further NHS providers to follow in 2026.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that the PreciseOnco consortium, coordinated by Philips, has been awarded funding from the EU’s Innovative Health Initiative (IHI) to advance precision cancer treatment through the integration of advanced medical imaging, robotic assistance, and minimally invasive therapies. Sword Intelligence has launched in the UK and Europe to bring AI-led care operations designed to help healthcare providers improve access, manage demand and reduce delays across care pathways,
Patients at James Paget University Hospitals NHS Foundation Trust are set to benefit from a new digital bedside service following a partnership with Airwave Healthcare, introducing integrated technology that supports entertainment, communication, and access to hospital services.
The new bedside terminals are being introduced on the trust’s innovative and award-winning Concept Ward as part of the Future Paget Programme.
The confirmation recognises the use of X-on Health’s Surgery Intellect incorporating ambient voice capability using TORTUS technology, supporting GP practices to reduce administrative burden and free up valuable clinical time.
Merck, a leading science and technology company, announced the launch of the ChemiSphere® app, a digital tool that allows scientists to instantly access product documentation and quality information via 2D barcodes on the Life Science products offered by Merck. The app is powered by the company’s secure digital traceability platform M-Trust™ and is designed to make data retrieval faster and more reliable, helping labs reduce manual steps and improve data integrity.
Siemens Healthineers is to co-lead a major EU research initiative dedicated to improving the diagnosis, treatment and monitoring of Alzheimer’s Disease (AD). The project, ACCESS-AD, aims to create a collaborative, patient-centered strategy for Alzheimer’s care across Europe. It begins in January 2026 and unites more than 30 European partners from hospitals, universities, patient organizations, and industry, representing expertise in neurology, imaging, data science, and patient advocacy.